Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue?

被引：756

作者：

Earle, Craig C.

Landrum, Mary Beth

Souza, Jeffrey M.

Neville, Bridget A.

Weeks, Jane C.

Ayanian, John Z.

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 23期

关键词：

D O I：

10.1200/JCO.2007.15.8253

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The purpose of this article is to review the literature and update analyses pertaining to the aggressiveness of cancer care near the end of life. Specifically, we will discuss trends and factors responsible for chemotherapy overuse very near death and underutilization of hospice services. Whether the concept of overly aggressive treatment represents a quality-of-care issue that is acceptable to all involved stakeholders is an open question.

引用

收藏

页码：3860 / 3866

页数：7

相关论文

共 39 条

[1] Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium [J].

Ayanian, JZ ;

Chrischilles, EA ;

Wallace, RB ;

Fletcher, RH ;

Fouad, MN ;

Kiefe, CI ;

Harrington, DP ;

Weeks, JC ;

Kahn, KL ;

Malin, JL ;

Lipscomb, J ;

Potosky, AL ;

Provenzale, DT ;

Sandler, RS ;

van Ryn, M ;

West, DW .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :2992-2996

[2] Resurrecting treatment histories of dead patients - A study design that should be laid to rest [J].

Bach, PB ;

Schrag, D ;

Begg, CB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (22) :2765-2770

[3] Are regional variations in end-of-life care intensity explained by patient preferences? A study of the US medicare population [J].

Barnato, Amber E. ;

Herndon, M. Brooke ;

Anthony, Denise L. ;

Gallagher, Patricia M. ;

Skinner, Jonathan S. ;

Bynum, Julie P. W. ;

Fisher, Elliott S. .

MEDICAL CARE, 2007, 45 (05) :386-393

[4] A STOPPING RULE FOR STANDARD CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - LESSONS FROM A SURVEY OF MARYLAND MEDICAL ONCOLOGISTS [J].

BENNER, SE ;

FETTING, JH ;

BRENNER, MH .

CANCER INVESTIGATION, 1994, 12 (05) :451-455

[5]

Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P526

[6] Survival of Medicare patients after enrollment in hospice programs [J].

Christakis, NA ;

Escarce, JJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :172-178

[7] Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients [J].

Daugherty, CK .

CANCER INVESTIGATION, 2004, 22 (01) :123-131

[8] THE QUALITY OF CARE - HOW CAN IT BE ASSESSED [J].

DONABEDIAN, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (12) :1743-1748

[9] Looking back from death: The value of retrospective studies of end-of-life care [J].

Earle, CC ;

Ayanian, JZ .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :838-840

[10] Evaluating claims-based indicators of the intensity of end-of-life cancer care [J].

Earle, CC ;

Neville, BA ;

Landrum, MB ;

Souza, JM ;

Weeks, JC ;

Block, SD ;

Grunfeld, E ;

Ayanian, JZ .

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2005, 17 (06) :505-509

← 1 2 3 4 →